Capital Building in Washington DC

Advocacy & Policy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • What Oncologists Need to Know About Biosimilars

    In the latest ASCO in Action podcast, Dr. Gary H. Lyman, MPH, FASCO, FRCP, joins ASCO CEO Dr. Clifford A. Hudis to discuss biosimilars and what oncologists need to know about including them in their treatment plans.

    Listen Now
  • Key Facts About Federal Funding for Cancer Research

    ASCO’s updated policy issue brief provides a snapshot and key data on the state of federal cancer research funding today and the role it plays in fueling breakthroughs in cancer care and treatment.

    Read the Brief
  • 2018-19 ASCO Health Policy Fellows Selected

    Trevor Royce, MS, MD, MPH, and Sheetal Kircher, MD, have been selected for the ASCO Health Policy Fellowship Program, which offers oncologists the opportunity to gain the knowledge-base, skills, and experience necessary to shape regulatory and legislative policies impacting the cancer community.

    Read More

Random Quote

"ASCO is the world’s largest and arguably most influential oncology organization… a dynamic organization that not only is advancing the frontiers of research, providing outstanding educational opportunities, and defining standards of practice for clinical care, but also influencing public policy."
Anees Chagpar, MD
ASCO Member since 2003